An anti-Alzheimer’s drug could enhance this high-risk action. Is it worth buying it here?

An anti-Alzheimer’s drug could enhance this high-risk action. Is it worth buying it here?

vTv Therapeutics (VTVT) is a $156 million biopharmaceutical company focused on small molecule drugs for Alzheimer’s, diabetes and inflammatory disorders, all in clinical trials. VTVT has surged 182% over the past year, hitting a two-year high, with strong technical momentum. Wall Street is leaning toward “strong buy” with targets of up to $47, but some…

Read More
Buy on the dip or panic sell? What this powerful chart indicator tells us about the current stock market.

Buy on the dip or panic sell? What this powerful chart indicator tells us about the current stock market.

The TTM Squeeze is a powerful volatility indicator that identifies periods of low volatility and anticipates potential breakouts. However, it can sometimes also indicate periods of indecision and lack of conviction. Pulling today’s results from Barchart’s investment ideas page, TTM Squeeze Triggered, highlights exactly this mood in the market. This list represents restricted candidates whose…

Read More